ArticleCancer2018

Targeting HER2 in colorectal cancer: The landscape of amplification and short variant mutations in ERBB2 and ERBB3.

Jeffrey S Ross et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.